03-03-2017 13:30 - 13:45
Welcome to the Conference
Auditorium
1 2 1 2 Moderation: S. Rauh , D. Arnold ; Esch/alzette, LU, Lisbon, PT 13:30 - 13:45
Welcome to the Conference S. Rauh, Esch/alzette, LU
13:45 - 14:15
Gene profiling in breast cancer
Auditorium
Moderation: S. Rauh, Esch/alzette, LU
13:45 - 14:05
Gene profiling in breast cancer
14:30 - 16:00
ESMO 2017 standards in Breast cancer
Auditorium
1 2 1 2 Moderation: S. Braga , I. Vaz-Luis ; Lisbon, PT, Boston, Ma, US 14:30 - 14:40
Introduction S. Braga, Lisbon, PT
14:40 - 14:55
Standards of care in Breast cancer: Neo-adjuvant treatment in HER2 positive I. Vaz-Luis, Boston, Ma, US
14:55 - 15:05
Q&A
15:05 - 15:15
Case presentation: Complete response: Should we try to achieve it with neo-adjuvant treatment in every breast cancer? I. Vaz-Luis, Boston, Ma, US
15:15 - 15:30
Discussion S. Braga, Lisbon, PT
15:30 - 15:40
Case presentation: TNBC / androgen receptor impact I. Vaz-Luis, Boston, Ma, US
15:40 - 15:55
Discussion S. Braga, Lisbon, PT
15:55 - 16:00
Conclusions and future outlook I. Vaz-Luis, Boston, Ma, US
Last update: 22-11-2016 10:04:12am
Term: FINAL_PROGRAMM_PDF_FOOTER_RIGHT
16:30 - 18:00
ESMO 2017 standards in GI cancers: Colorectal cancer
Auditorium
1 2 1 2 Moderation: M. Karamouzis , D. Arnold ; Athens, GR, Lisbon, PT 16:30 - 16:40
Introduction M. Karamouzis, Athens, GR
16:40 - 16:55
Standards of care in metastatic colorectal cancer: What is new in 2016/17? D. Arnold, Lisbon, PT
16:55 - 17:05
Q&A
17:05 - 17:15
Case presentation: Right vs left side: Is this the commander for therapeutic strategy? D. Arnold, Lisbon, PT
17:15 - 17:30
Discussion M. Karamouzis, Athens, GR
17:30 - 17:40
Case presentation: What is the standard “beyond combination treatment”: The field of refractory mCRC D. Arnold, Lisbon, PT
17:40 - 17:55
Discussion M. Karamouzis, Athens, GR
17:55 - 18:00
Conclusions and future outlook D. Arnold, Lisbon, PT
03-04-2017 08:30 - 09:00
Oligometastatic disease: Only an early stage of metastasization or a new “sub-entity”? Implications for diagnostic and treatment strategies
Auditorium
Moderation: S. Rauh, Esch/alzette, LU
08:30 - 09:00
Oligometastatic disease: Only an early stage of metastasization or a new “sub-entity”? Implications for diagnostic and treatment strategies D. Arnold, Lisbon, PT
Last update: 22-11-2016 10:04:12am
Term: FINAL_PROGRAMM_PDF_FOOTER_RIGHT
09:00 - 10:30
ESMO 2017 standards in upper GI cancers (Gastroesophageal)
Auditorium
1 2 1 2 Moderation: G. Lakatos , M. Ducreux ; Budapest, HU, Villejuif, FR 09:00 - 09:10
Introduction G. Lakatos, Budapest, HU
09:10 - 09:25
Standards of care in upper GI cancers M. Ducreux, Villejuif, FR
09:25 - 09:35
Q&A
09:35 - 09:45
Case presentation: Role of neo-adjuvant treatment in gastroesophageal cancers M. Ducreux, Villejuif, FR
09:45 - 10:00
Discussion G. Lakatos, Budapest, HU
10:00 - 10:10
Case presentation: Surgical limits for curative treatment in locally advanced pancreatic cancer M. Ducreux, Villejuif, FR
10:10 - 10:25
Discussion G. Lakatos, Budapest, HU
10:25 - 10:30
Conclusions and future outlook M. Ducreux, Villejuif, FR
Last update: 22-11-2016 10:04:12am
Term: FINAL_PROGRAMM_PDF_FOOTER_RIGHT
11:00 - 12:30
ESMO 2017 standards in GU cancers
Auditorium
1 2 1 2 Moderation: M. Schmidinger , S. Oudard ; Wien, AT, Paris, FR 11:00 - 11:10
Introduction M. Schmidinger, Wien, AT
11:10 - 11:25
Standards of care in Prostate cancer S. Oudard, Paris, FR
11:25 - 11:35
Questions and Answers
11:35 - 11:45
Case presentation: Metastatic prostate cancer upon initial diagnosis S. Oudard, Paris, FR
11:45 - 12:00
Discussion M. Schmidinger, Wien, AT
12:00 - 12:10
Case presentation: 2nd line treatment for renal cancer M. Schmidinger, Wien, AT
12:10 - 12:25
Discussion S. Oudard, Paris, FR
12:25 - 12:30
Conclusions and future outlook M. Schmidinger, Wien, AT
Last update: 22-11-2016 10:04:12am
Term: FINAL_PROGRAMM_PDF_FOOTER_RIGHT
14:00 - 15:30
ESMO 2017 standards in Gynaecological cancers
Auditorium
1 2 1 2 Moderation: R. Eckert , S. Banerjee ; Esslingen, DE, London, GB 14:00 - 14:10
Introduction R. Eckert, Esslingen, DE
14:10 - 14:25
Standards of care in Gynaecological cancers S. Banerjee, London, GB
14:25 - 14:35
Q&A
14:35 - 14:45
Case presentation S. Banerjee, London, GB
14:45 - 15:00
Discussion R. Eckert, Esslingen, DE
15:00 - 15:10
Case presentation S. Banerjee, London, GB
15:10 - 15:25
Discussion R. Eckert, Esslingen, DE
15:25 - 15:30
Conclusions and future outlook S. Banerjee, London, GB
Last update: 22-11-2016 10:04:12am
Term: FINAL_PROGRAMM_PDF_FOOTER_RIGHT
16:00 - 17:30
ESMO 2017 standards in NSCLC
Auditorium
1 2 1 2 Moderation: S. Peters , S. Rauh ; Lausanne, CH, Esch/alzette, LU 16:00 - 16:10
Introduction S. Rauh, Esch/alzette, LU
16:10 - 16:25
Standards of care in NSCLC S. Peters, Lausanne, CH
16:25 - 16:35
Q&A
16:35 - 16:45
Case presentation: Immuno / cisplatin-based chemo in 1st line S. Peters, Lausanne, CH
16:45 - 17:00
Discussion S. Rauh, Esch/alzette, LU
17:00 - 17:10
Case presentation: Strategy based on clinical presentation: Fast progressor, slow progressor oligometastatic, low symptom burden S. Peters, Lausanne, CH
17:10 - 17:25
Discussion S. Rauh, Esch/alzette, LU
17:25 - 17:30
Conclusions and future outlook S. Peters, Lausanne, CH
17:30 - 18:00
Option and limits of liquid biopsies/circulating DNA in current cancer therapy
Auditorium
Moderation: S. Braga, Lisbon, PT
17:30 - 17:50
Option and limits of liquid biopsies/circulating DNA in current cancer therapy K. Spindler, Aarhus, DK
03-05-2017
Last update: 22-11-2016 10:04:12am
Term: FINAL_PROGRAMM_PDF_FOOTER_RIGHT
08:30 - 09:30
New drug toxicity
Auditorium
1 2 1 2 Moderation: L. Costa , S. Rauh ; Lisbon, PT, Esch/alzette, LU 08:30 - 08:40
Introduction S. Rauh, Esch/alzette, LU
08:40 - 08:55
Management of toxicity from new drugs L. Costa, Lisbon, PT
08:55 - 09:00
Q&A
09:00 - 09:10
Case presentation L. Costa, Lisbon, PT
09:10 - 09:25
Discussion S. Rauh, Esch/alzette, LU
09:25 - 09:30
Conclusions and future outlook L. Costa, Lisbon, PT
09:30 - 10:00
Using e-tools in everyday oncology practice: Symptom monitoring
Auditorium
Moderation: S. Rauh, Esch/alzette, LU
09:30 - 09:45
Using e-tools in everyday oncology practice: Symptom monitoring L. Hochstenbach, Heerlen, NL
09:45 - 10:00
Discussion
Last update: 22-11-2016 10:04:12am
Term: FINAL_PROGRAMM_PDF_FOOTER_RIGHT
10:30 - 11:30
Supportive and Palliative care/Symptom control
Auditorium
1 2 1 2 Moderation: R. Curca , F. Strasser ; Alba Iulia, RO, St Gallen, CH 10:30 - 10:40
Introduction R. Curca, Alba Iulia, RO
10:40 - 10:55
Standards in supportive and palliative care/symptom control F. Strasser, St Gallen, CH
10:55 - 11:00
Q&A
11:00 - 11:10
Case presentation F. Strasser, St Gallen, CH
11:10 - 11:25
Discussion R. Curca, Alba Iulia, RO
11:25 - 11:30
Conclusions and future outlook F. Strasser, St Gallen, CH
11:30 - 11:45
Closing remarks
Auditorium
1 2 1 2 Moderation: S. Rauh , D. Arnold ; Esch/alzette, LU, Lisbon, PT 11:30 - 11:45
Closing remarks
Last update: 22-11-2016 10:04:12am
Term: FINAL_PROGRAMM_PDF_FOOTER_RIGHT
